Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma

Published:2017-03-14 Issue:23 Volume:8 Page:37080-37090
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fang Min¹,Song Tao¹,Liang Xiaodong¹,Lv Shiliang¹,Li Jianbo²,Xu Hong’en¹,Luo Limin¹,Jia Yongshi¹

Affiliation:

1. Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310000, Zhejiang, P. R. China

2. Department of Radiation Oncology, Ningbo Mingzhou Hospital, Ningbo 315000, Zhejiang, P. R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis;Current Oncology;2022-09-16

2. Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence;Cancer Medicine;2021-10-27

3. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma;Investigational New Drugs;2019-10-24

4. The optimal neoadjuvant treatment of locally advanced esophageal cancer;Journal of Thoracic Disease;2019-04

The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

;Drug Design, Development and Therapy;2019-02